Drug Repurposing for Vascular Protection After Acute Ischemic Stroke
Authors:
- 24 May 2011
- book chapter
- Published by Springer Nature
- Vol. 111, 295-298
Abstract
The attempts to develop new treatments for acute ischemic stroke have been fraught with costly and spectacularly disappointing failures. Repurposing of safe, older drugs provides a lower risk alternative. Vascular protection is a novel strategy for improving stroke outcome. Promising targets for vascular protection after stroke have been identified, and several of these targets can be approached with “repurposed” old drugs, including statins, angiotensin receptor blockers (ARBs), and minocycline. We tested the vascular protection (ability to reduce hemorrhagic transformation) of three marketed drugs (candesartan, minocycline, and atorvastatin) in the experimental stroke model using three different rat strains [Wistar, spontaneously hypertensive rats (SHR) and type 2 diabetic Goto-Kakizaki (GK) rats]. All agents decreased the infarct size, improved the neurological outcome and decreased bleeding. Mechanisms identified include inhibition of MMP-9, activation of Akt, and increased expression of proangiogenic growth factors. Premorbid vascular damage (presence of either diabetes or hypertension) increased the likelihood of vascular injury after ischemia and reperfusion and improved the response to vascular protection.Keywords
This publication has 13 references indexed in Scilit:
- Minocycline and Tissue-Type Plasminogen Activator for StrokeStroke, 2009
- Candesartan Augments Ischemia-Induced Proangiogenic State and Results in Sustained Improvement After StrokeStroke, 2009
- Vascular Protection with Candesartan after Experimental Acute Stroke in Hypertensive Rats: A Dose-Response StudyThe Journal of Pharmacology and Experimental Therapeutics, 2008
- The prince and the pauper. A tale of anticancer targeted agentsMolecular Cancer, 2008
- Blood pressure lowering after experimental cerebral ischemia provides neurovascular protectionJournal Of Hypertension, 2007
- Hypertension after experimental cerebral ischemia: candesartan provides neurovascular protectionJournal Of Hypertension, 2006
- Tactics for Vascular Protection After Acute Ischemic StrokePharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2005
- Targets for Vascular Protection After Acute Ischemic StrokeStroke, 2004
- Single slice method for quantification of hemorrhagic transformation using direct ELISANeurological Research, 2004
- Reversible middle cerebral artery occlusion without craniectomy in rats.Stroke, 1989